CO168 A Propensity Score-Based Comparison of Tepotinib Versus Immunotherapy with/without Chemotherapy, Using Real-World Data in Previously Untreated Met Exon 14 (METEX14) Skipping Non-Small Cell Lung Cancer (NSCLC)
Abstract
Authors
E. Hook R. Batteson P. Christopoulos F. Guisier S. Ekman A. Hatswell H. Vioix